Literature DB >> 28890378

MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.

Chunyan Wei1, Xi Zhang2, Sai He3, Bianli Liu1, Hongfang Han1, Xuejun Sun4.   

Abstract

MicroRNAs are emerging as critical regulators in various fundamental biological processes, including tumor progression. MicroRNA-219-5p (miR-219-5p) has been suggested as a novel tumor suppressing miRNA for many types of human cancers. However, the expression and functional significance of miR-219-5p in epithelial ovarian cancer remain poorly understood. In this study, we sought to explore the potential functions of miR-219-5p in epithelial ovarian cancer. Herein, we found that miR-219-5p levels were significantly decreased in epithelial ovarian cancer tissues and cell lines. Further experiments showed that overexpression of miR-219-5p inhibited epithelial ovarian cancer cell proliferation, migration, and invasion, and suppressed the Wnt/β-catenin signaling pathway. By contrast, suppression of miR-219-5p exhibited the opposite effects. Twist was identified as a downstream target of miR-219-5p, and its expression was directly regulated by miR-219-5p. Restoration of Twist expression in miR-219-5p-overexpresing cells significantly reversed the antitumor effects of miR-219-5p. Taken together, our results revealed a tumor suppressive role for miR-219-5p in epithelial ovarian cancer that includes suppression of cell proliferation, migration, and invasion through downregulation of the Twist/Wnt/β-catenin signaling pathway. Our study suggests that miR-219-5p may have potential applications in the diagnosis and treatment of epithelial ovarian cancer.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epithelial ovarian cancer; Twist; Wnt; miR-219-5p

Mesh:

Substances:

Year:  2017        PMID: 28890378     DOI: 10.1016/j.gene.2017.09.012

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

Review 1.  A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

Authors:  Ahmad Saburi; Mohammad Saeed Kahrizi; Navid Naghsh; Hasti Etemadi; Ahmet İlhan; Ali Adili; Shadi Ghoreishizadeh; Rozita Tamjidifar; Morteza Akbari; Gülinnaz Ercan
Journal:  J Ovarian Res       Date:  2022-07-07       Impact factor: 5.506

2.  miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.

Authors:  Tao Wei; Shan Cheng; Xiao Na Fu; Lian Jie Feng
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

3.  MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.

Authors:  Feng Xing; Zhijiao Song; Yuanying He
Journal:  Biol Res       Date:  2018-11-24       Impact factor: 5.612

Review 4.  Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.

Authors:  Lízbeth Ayala-Domínguez; Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Joaquín Manzo-Merino; Imelda Martínez-Ramírez; Marcela Lizano
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

5.  miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6.

Authors:  Qi Chen; Dan Liu; Zhi Hu; Cheng Luo; Si Lin Zheng
Journal:  Onco Targets Ther       Date:  2019-01-25       Impact factor: 4.147

6.  LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.

Authors:  Lihong Wang; Tian Luan; Shunheng Zhou; Jing Lin; Yue Yang; Wei Liu; Xiao Tong; Wei Jiang
Journal:  Cancer Med       Date:  2019-06-18       Impact factor: 4.452

Review 7.  Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance.

Authors:  Miriam Teeuwssen; Riccardo Fodde
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

8.  MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.

Authors:  Yan Shi; Shenglan Dai; Caiyu Qiu; Tao Wang; Yong Zhou; Cuihua Xue; Jun Yao; Yaping Xu
Journal:  Mucosal Immunol       Date:  2019-10-18       Impact factor: 7.313

9.  RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.

Authors:  Sung-Hwa Sohn; Hee Jung Sul; Bohyun Kim; Hyeong Su Kim; Bum Jun Kim; Hyun Lim; Ho Suk Kang; Jae Seung Soh; Kab Choong Kim; Ji Woong Cho; Jinwon Seo; Youngho Koh; Dae Young Zang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

Review 10.  Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.

Authors:  Vu Hong Loan Nguyen; Rebecca Hough; Stefanie Bernaudo; Chun Peng
Journal:  J Ovarian Res       Date:  2019-12-11       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.